MENU

3 stellar ASX shares for growth investors

If you’re a fan of growth shares then you’re in luck. In my opinion, there are a large number of quality growth shares for investors to choose from on the Australian share market.

Listed below are three of my favourites that I believe are trading on fair valuations given their current growth profiles. Here’s why I like them:

A2 Milk Company Ltd (ASX: A2M)

Last month this fast-growing infant formula and dairy company provided full-year sales guidance of between NZ$900 million and NZ$920 million. While this means growth of up to 67% on last year’s result, it wasn’t enough for some investors it seems. Since that release a2 Milk Company’s shares have fallen by around 13%. I think this is a buying opportunity for investors that are willing to hold on for the long-term.

Aristocrat Leisure Limited (ASX: ALL)

Another company that updated the market last month was Aristocrat Leisure with its half-year release. But unlike a2 Milk Company, this gaming technology company’s numbers were well ahead of expectations. Aristocrat Leisure delivered an impressive 24.4% increase in net profit after tax during the half. This was thanks to a strong performance from its core pokie machine business and an even stronger performance from its digital business. Due to the acquisitions of Plarium and Big Fish, together with the continued success of its own digital portfolio, the number of digital daily active users grew 493% to 8.9 million. I think the recurring revenues that these users generate is highly attractive and puts the company in a position to continue growing its bottom line at an above-average rate for the next few years.

ResMed Inc. (ASX: RMD)

ResMed is a sleep treatment company which I think would be ideal for growth investors. Thanks to its industry-leading products the company recently posted a solid 32% increase in quarterly profit to US$132.5 million. Considering the sleep treatment market is expected to grow strongly over the next decade and its expansion into software has been a big success, I expect more above-average profit growth over the coming years from ResMed.

Top 3 ASX Growth Shares To Buy In June

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!